A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

2018-04-23T11:33:14+03:00

A risk-based approach to optimize autologous hematopoietic stem cell (HSC) collection with the use of plerixafor

2018-04-11T05:48:25+03:00
Go to Top